Related Experiment Video
Updated: May 18, 2026
11:04
Evaluation of the Impact of Protein Aggregation on Cellular Oxidative Stress in Yeast
Published on: June 23, 2018
Correlation between protective immunity to α-synuclein aggregates, oxidative stress and inflammation
Neuroimmunomodulation
|September 19, 2012
Summary
Parkinson's disease involves alpha-synuclein aggregation, inflammation, and oxidative stress. This study found that autoimmune responses to alpha-synuclein correlate with these factors, suggesting a protective role for humoral immunity in neurodegeneration.
Area of Science:
- Neuroimmunology
- Protein Misfolding Diseases
- Oxidative Stress
Background:
- Protein aggregation and amyloid deposition, particularly of alpha-synuclein, are central to Parkinson's disease (PD) pathogenesis.
- Disease progression in PD is often accompanied by inflammation and oxidative stress.
- Humoral immune responses may arise against pathological alpha-synuclein aggregates during PD.
Purpose of the Study:
- To investigate the potential link between autoimmune responses to different forms of alpha-synuclein (monomers, oligomers, fibrils) and markers of oxidative stress and inflammation in Parkinson's disease.
Main Methods:
- Assessed alpha-synuclein amyloid formation using thioflavin-T assay and atomic force microscopy.
- Quantified serum autoantibody titers against alpha-synuclein conformations via ELISA.
- Measured enzyme activities and concentrations of oxidative stress and inflammatory markers using enzyme and ELISA protocols.
Main Results:
- PD patients showed increased autoantibody titers to alpha-synuclein species, elevated pro-inflammatory cytokines (IL-6, TNF-α), and reduced interferon-γ.
- Increased levels of malondialdehyde and reduced glutathione were observed.
- Activities of antioxidant enzymes (superoxide dismutase, catalase, glutathione transferase) were decreased in PD patients.
Conclusions:
- Hypothesize that alpha-synuclein aggregation, oxidative stress, and inflammation trigger humoral immunity, potentially protecting against dopaminergic neuronal death.
- Humoral immunity appears to be an integrative factor in PD progression, aimed at preventing further neurodegeneration.
- Future therapeutic strategies for PD should consider maintaining the immune status of patients.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:19Psychoneuroimmunology: Diabetes and Cancer
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...